In vivo suppression of HIV rebound by didehydro-Cortistatin A, a ‘block-and-lock’ strategy for HIV-1 cure

• C.F. Kessing,
• C.C. Nixon,
• C. Li,
• P.M. Tsai,
• H. Takata,
• G. Mousseau,
• P.T. Ho,
• J.B. Honeycutt,
• M. Fallahi,
• L. Trautmann,
• J.V. Garcia,
• S.T. Valente

Affiliations

C.F. Kessing

Department of Immunology and Microbial Sciences, Scripps Research Institute, Jupiter, FL, USA

C.C. Nixon

University of North Carolina, School of Medicine, Chapel Hill, NC, USA

C. Li

Department of Immunology and Microbial Sciences, Scripps Research Institute, Jupiter, FL, USA

P.M. Tsai

University of North Carolina, School of Medicine, Chapel Hill, NC, USA

H. Takata

Walter Reed Army Institute of Research, Silver Spring, MD USA; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA

G. Mousseau

Department of Immunology and Microbial Sciences, Scripps Research Institute, Jupiter, FL, USA

P.T. Ho

University of North Carolina, School of Medicine, Chapel Hill, NC, USA

J.B. Honeycutt

University of North Carolina, School of Medicine, Chapel Hill, NC, USA

M. Fallahi

Department of Immunology and Microbial Sciences, Scripps Research Institute, Jupiter, FL, USA

L. Trautmann

Walter Reed Army Institute of Research, Silver Spring, MD USA; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA

J.V. Garcia

University of North Carolina, School of Medicine, Chapel Hill, NC, USA

S.T. Valente

Department of Immunology and Microbial Sciences, Scripps Research Institute, Jupiter, FL, USA